☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
In-License
Almirall Signs an In-License Agreement with 23andMe for Multiple Inflammatory Diseases
January 9, 2020
Biocon Biologics Signs an In-License Agreement with Just - Evotec Biologics
October 11, 2019
Oncology Venture Signs an Exclusive Option Agreement to In-License Commercialization Rights for R-Pharm's Ixempra (ixabepilone) in...
April 5, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
